Financials
- Market Capitalization 16.37 M
- Employee 5
- Founded 2020
- CEO N/A
- Website www.pasithea.com
- Headquarter Delaware, United States
- FIGI BBG01018ZGY8
- Industry Biotechnology
Related tickers
| # | Name | Price | 24h % | 7d % | 1M % | 1Y % | Market Cap | Last 7 Days | |
|---|---|---|---|---|---|---|---|---|---|
| 4680 | CYCN Cyclerion Therapeutics, Inc. - Common Stock | 3.70 USD | -4.64% | +7.25% | +11.78% | +13.85% | 16.02 M USD | ||
| 4682 | HOWL Werewolf Therapeutics, Inc. - Common Stock | 0.32 USD | -5.88% | +3.23% | -15.79% | -75.38% | 15.55 M USD | ||
| 4700 | HIND Vyome Holdings, Inc. - Common Stock | 2.24 USD | 0.00% | +2.75% | +3.23% | -84.29% | 15.72 M USD | ||
| 4706 | AKTX Akari Therapeutics Plc - American Depositary Shares | 13.10 USD | -2.24% | +10.64% | -2.60% | +1080.18% | 14.99 M USD |
Frequently asked questions about Pasithea Therapeutics Corp. - Common Stock
What is the Pasithea Therapeutics Corp. - Common Stock stock price today?
The current price of Pasithea Therapeutics Corp. - Common Stock (KTTA) is 0.49. Over the past 24 hours, the stock has changed by 0.00%. Follow the KTTA chart for real-time price dynamics.
What is the stock ticker of Pasithea Therapeutics Corp. - Common Stock?
Pasithea Therapeutics Corp. - Common Stock trades under the ticker KTTA. Tickers can differ by exchange, so always check the exchange and instrument details before trading.
Is Pasithea Therapeutics Corp. - Common Stock stock going up?
KTTA has changed by -3.92% over the last week, -15.52% over the last month, and -28.99% over the last year. Review the chart to see whether the current move is part of a broader trend.
What was Pasithea Therapeutics Corp. - Common Stock net income for the last quarter?
Pasithea Therapeutics Corp. - Common Stock reported net income of -2.87 M for the last quarter. The previous quarter showed -10.11 M, which means net income changed by +71.62%.
How many employees does Pasithea Therapeutics Corp. - Common Stock have?
As of the latest available data, Pasithea Therapeutics Corp. - Common Stock has 5 employees. Workforce size can provide additional context about the company's scale and operations.
What is Pasithea Therapeutics Corp. - Common Stock EBITDA?
Pasithea Therapeutics Corp. - Common Stock EBITDA is -1.79 M, and its EBITDA margin is 18.82 K%. EBITDA is commonly used to evaluate operating performance before interest, taxes, depreciation, and amortization.
How can I buy Pasithea Therapeutics Corp. - Common Stock stock?
You can buy Pasithea Therapeutics Corp. - Common Stock (KTTA) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.
Should I invest in Pasithea Therapeutics Corp. - Common Stock stock?
Investing in Pasithea Therapeutics Corp. - Common Stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the KTTA chart and related analysis on metatrader.com as part of your research.